During the AD/PD 2026 “AI and digital tools for AD/PD care” presentation, Roche also introduced a new concept of shifting the efficacy paradigm for measuring disease progression in PD. Credit: ...

Connecting the dots: Early reactions to Nvidia's DLSS 5 were swift and skeptical, with some observers likening the technology to an Instagram-style filter applied over gameplay footage. Nvidia CEO ...

Abstract 701 - Results from REACT-PD - a randomised, placebo-controlled, multi-centre phase IIb study evaluating the efficacy of pirepemat on falls frequency in patients with Parkinson's disease will ...

Phase 1b data on Lu AF28996, an investigational treatment for people with advanced Parkinson's disease, to be presented at the 2026 AD/PD™ Conference Data evaluated safety, tolerability, ...

Grafana’s query editors are unique for each data source. For general information on Grafana query editors, refer to Query editors. For general information on querying data sources in Grafana, refer to ...

Schemas, and Composable DataFrame ContractsIn this tutorial, we demonstrate how to build robust, production-grade data validation pipelines using Pandera with typed DataFrame models. We start by ...

SYDNEY, Jan. 30, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, today announced ...

New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx’s TAMP Therapy Platform as a Targeted Drug-Delivery Approach Data Shows a ...

Mayor John Vieau talks to the City Council about a new five-year contract for the Peregrine Software Technologies’ data integration and analytics platform, which will be used inside the city’s new ...

Add Yahoo as a preferred source to see more of our stories on Google. Although the Eugene Police Department eventually shut it off, federal immigration enforcement officials initially had access to ...

MIAMI, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic oral ...

As AI becomes more common and decisions more data-driven, a new(ish) form of information is on the rise: synthetic data. And some proponents say it promises more privacy and other vital benefits. Data ...